Funded Grants December 2021

PIAgencyTitle
Mohamed Abdelbaki SLCH FoundationNeuro Oncology and Investigational New Drug Support Year 9
Mohamed AbdelbakiNIH/R01/University of Alabama at BirminghamPh1 Study of HSV G207 in Pediatric Malignant Cerebellar Tumors IND
Megan CooperNIH/R21Genetic Mosaicism in Inborn Errors of Immunity
Patricia DicksonNIH/R33Recombinant Alpha-N-Acetylglucosaminidase with Improved Mannose 6-Phosphorylation for Treatment of Sanfilippo B Syndrome
Patricia DicksonAlnylamTesting a Substrate Reduction Approach for Mucopolysaccharidosis (MPS)
Robert HayashiSLCH FoundationSLCH Audiology Year 4
David RudnickNIH/R01Novel therapies that target mitochondrial dysfunction for treatment or a1-antitrypsin deficiency liver disease
Kentaro YomogidaNIH/K08Impact of Aiolos on intestinal intraepithelial lymphocytes
Funded Awards
Funded Grants March 2022

PI Agency Title Andrew Cluster University of California A Phase 1 Study of Modified Measles Virus (MV-NIS) for the Treatment of Children and Young Adults with Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT) Jonathan Cooper NIH/R21 Defining and treating peripheral nervous system dysfunction in Cln1 disease Megan Cooper …

Funded Awards
Funded Grants February 2022

PI Agency Title Tarin Bigley Rheumatology Research Foundation/Scientist Development Award Evaluating the role of neonatal infections in systemic lupus erythematosus Jane Garbutt NIH/UL1 Washington University Institute of Clinical and Translational Sciences (ISP, JG) (WUPAARC) Bryan Sisk SLCH Foundation Transitioning from hospital-based care to home-based care for pediatric patients and families …

Funded Awards
Funded Grants January 2022

PI Agency Title Mohamed Abdelbaki SLCH Foundation Neuro-Onc Fellowship Year 2 Sarah Garwood SLCH Foundation The SPOT at Jennings High School (A School-Based Health Center) Robert Hayashi St. Baldrick’s Foundation/Children’s Hospital of Philadelphia Health Effects After Anthracycline and Radiation Therapy (HEART) – Dexazoxane and Prevention of Anythracycline-related Cardiomyopathy (ALTE11C2) Jennifer …